Thrombotic microangiopathy associated with interferon beta
about
Drug-induced glomerular disease: attention required!Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosisDrug-induced glomerular disease: direct cellular injury.Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1aInterferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.Paying physicians to prescribe generic drugs and follow-on biologics in the United States.Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.Traceability of biologicals: present challenges in pharmacovigilance.Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.Type I interferon dysregulation and neurological disease.Some recent advances in multiple sclerosis.The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.Can new chemical therapies improve the management of multiple sclerosis in children?Active Surveillance of Follow-on Biologics: A Prescription for Uptake.Detection of interferon alpha protein reveals differential levels and cellular sources in disease.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.Association between beta-interferon exposure and hospital events in multiple sclerosis.Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed.Maintaining consistent quality and clinical performance of biopharmaceuticals.Anticancer Drug-Induced Acute Kidney Injury.[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].[Current immunotherapy of multiple sclerosis].Neurological Disease in Lupus: Toward a Personalized Medicine Approach.
P2860
Q26829793-5410244A-97F5-48DF-A658-C41BD5D73349Q26852672-DE182AA8-06FA-47DA-A64F-921633FD6AE9Q27692666-E1FF2905-F67E-4B3C-A5C0-4165C5795D06Q33422969-69C5094C-5B1E-4FD4-BAC8-FFD55720DE88Q33424731-C3C8E504-620D-4DE8-9EAC-8ECFC769F358Q33441871-7F9CFACB-B6AC-4356-8C91-C9EAD323AB62Q35189018-83D7F5BD-8E65-4B95-8AFE-B33A1956F98EQ37508060-0FDA8E7F-2361-4758-AD33-F7B944CBF7A6Q38264987-10819C27-8EA1-404F-B601-48863444997DQ38570380-4CC37A33-2600-463C-8ED2-942D0767977EQ38573095-2A621E0C-3ECC-40BA-B371-7D83AC9C17DAQ38817473-6B973481-0FF6-413B-B320-B6A79065C43CQ38931121-FC8F95A8-CD37-4099-BB0E-3F619B16C314Q39024427-265DE109-AD7C-4A47-B312-A60F74AFE609Q39192119-A94C798F-8112-4622-B1BF-161AECC8ADA7Q40237578-879B12B1-1569-4149-819D-EEAAF270C8C0Q42086661-6CDAD86A-D9E8-45C5-B669-6A1E2E9CE3F5Q42368351-0753FCD0-BE68-46C8-BB10-541184C0348DQ43995853-F35A7DA4-E3BF-4616-A64A-4457689D3F5CQ47120870-80D579D0-7C05-442A-91F0-95B7EAFC9562Q47246881-F6D9B29E-E667-4DD2-81CF-742E7E881D7EQ47261056-93433524-5253-46C5-97BA-A822B0DAF6D9Q52855510-1E55ECC4-1152-403C-B3FC-AA7ED90F23FFQ52863422-6ED53870-EBE3-4FB4-9A22-CB4C079F6FA6Q55267080-266751C9-AB3A-4097-AD91-4E6076BE64C5
P2860
Thrombotic microangiopathy associated with interferon beta
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Thrombotic microangiopathy associated with interferon beta
@ast
Thrombotic microangiopathy associated with interferon beta
@en
type
label
Thrombotic microangiopathy associated with interferon beta
@ast
Thrombotic microangiopathy associated with interferon beta
@en
prefLabel
Thrombotic microangiopathy associated with interferon beta
@ast
Thrombotic microangiopathy associated with interferon beta
@en
P2093
P356
P1476
Thrombotic microangiopathy associated with interferon beta
@en
P2093
Belinda Weller
Chris Bellamy
David Hunt
Iain Drummond
James Overell
Siddharthan Chandran
Stephen Evans
P304
P356
10.1056/NEJMC1316118
P407
P577
2014-03-01T00:00:00Z